31 results about "Diploclisia" patented technology

The invention provides medicine paste with functions of diminishing inflammation, relieving pain, activating blood circulation and dissipating blood stasis and a manufacturing method thereof. The mashed medicine comprises the following components: herb of decumbent bugle, ovalleaf dutchmanspipe root, stem of climbing entada, kadsura coccinea, stem of glaucescent diploclisia, pawpaw, dog bone, giant knotweed rhizome, rhizome of blackfruit greenbrier, rhizoma drynariae, herb of chrysanthemum-like groundsel, air plant, leaves of fig, peach kernel, saffron, sanguis draxonis, elderberry, native copper, the bark of eucommia, radix achyranthis bidentatae, himalayan teasel root, rhizoma ligustici wallichii, edible bird's nest, angelica, clematis root, cassia twigs, olibanum and myrrh. The manufacturing method comprises the following steps of: removing impurities from above traditional Chinese medicines, cutting up, and uniformly mixing according to the proportion, drying in the shade or sun, and then grinding into powders; filling the traditional Chinese medicine powders into wine to be soaked for about 3 months; and in use, mixing the medicine with flour and then externally applying the medicine paste on the wound parts. The manufacturing method of the medicine paste is simple, the components of the traditional Chinese medicine are not broken, and the medicine paste is easy to pack and save with long guarantee period. The invention is suitable for various acute or chronic muscle injury, bone muscle injury and joint injury.

The invention relates to a traditional Chinese medicine for treating middle-aged rheumatism and rheumatoid. The traditional Chinese medicine is prepared by the following raw materials in parts by weight: 1 part of angelica citriodorum, 5 parts of nude fern herb, 0.5 part of huperzia serrata, 1 part of goat blood, 2 parts of tall monkshood root, 1 part of hemp spike, 3 part of serrate-leaved chloranthus stem and leaf, 3 parts of bloodvine, 9 parts of cirsium setosum, 3 parts of mexican tea herb, 1 part of Chinese mahonia, 12 parts of creeping mallotus root leaf, 7 parts of lycopodium annotinum, 3 parts of mezoneuron, 1 part of red fennel root, 10 parts of celastrusgemmatus, 4 parts of herba fici, 2 parts of pratia nummularia, 1 part of capitate knotweed herb, 1 part of plectocomia assamica, 3 parts of gynura divaricata, 3 parts of ciliate desert-grass, 1 part of wallgermander, 0.5 parts of Diaoganma, 2 parts of herba Sambuci Chinensis and 3 parts of diploclisia affinis. Clinical experiments prove that the traditional Chinese medicine can treat middle-aged rheumatism and rheumatoid safely and effectively.

The invention discloses a drug for curing cholecystitis, and belongs to the field of traditional Chinese medicine. The effective component of the drug is composed of following raw materials: halenia elliptica D.don, cow pea pod, hypecoum erectum, herba aconite, negundo chastetree fruit, stigma of corn, nauclea officinalis, dandelion, herpetospermum caudigerum, diploclisia affinis, leaf of Yunnan machilus, potentilla fulgens wall, spicate clerodendranthus herb, phlomis umbrosa, chicken's gizzard membrane and homonoia riparia lour. The drug has the functions of clearing heat, removing toxicity, resolving inflammation, excreting gall-bladder, and promoting Qi circulation to relieve pain, improves the immunity functions of human bodies through orally taking the drug, and has prominent curative effects on cholecystitis caused by various reasons. The drug has the advantages of quick effect, high cure rate, good tolerance, low cost, no side or toxic effects and difficult recurrence after cure.